Figure 7.
Integrated CS-I/J@CM NPs remodel the tumor immunosuppressive microenvironment to improve glioblastoma immunotherapy [63].
Integrated CS-I/J@CM NPs remodel the tumor immunosuppressive microenvironment to improve glioblastoma immunotherapy [63].